Sihuan Pharmaceutical Gr... (SHPHF)

AI Score

Unlock

0.12

-0.00 (-1.48%)

At close: Apr 22, 2025, 8:00 PM

Sihuan Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	2.81B	1.86B	2.52B	1.46B	3.37B	3.32B	4.37B	3.68B	3.93B	4.52B	4.58B	4.22B	4.02B	4.54B	4.63B	4.58B	4.55B
Cost of Revenue	906.08M	564.89M	768.48M	460.51M	900.6M	721.39M	989.87M	846.67M	857.47M	874.74M	830.41M	875.33M	1.01B	1.3B	1.42B	1.44B	1.4B
Gross Profit	1.9B	1.3B	1.75B	1B	2.47B	2.6B	3.38B	2.84B	3.08B	3.64B	3.74B	3.35B	3.01B	3.25B	3.21B	3.14B	3.16B
Operating Income	185.15M	76.05M	135.16M	74.66M	825.84M	989.08M	1.24B	843.72M	1.64B	2.26B	2.76B	2.39B	2.33B	2.57B	2.73B	2.96B	2.9B
Interest Income	121.43M	121.43M	81.35M	25.26M	78.2M	114.83M	180.45M	183.01M	230.62M	253.69M	268M	211.4M	167.23M	165.64M	155.85M	149.46M	152.87M
Pretax Income	-180.47M	-161.26M	22.99M	56.04M	875.52M	1.28B	1.59B	47.79M	-2.12B	-1.33B	307.26M	2.74B	2.65B	2.99B	3.15B	3.31B	3.73B
Net Income	-87.44M	-54.02M	-9.27M	40.38M	651.8M	945.3M	1.12B	-203.09M	-2.53B	-1.86B	-378.01M	2.23B	2.21B	2.42B	2.55B	2.32B	2.8B
Selling & General & Admin	1.37B	911.22M	974.61M	549.95M	1.09B	1.05B	1.4B	1.24B	1.07B	1.1B	1.01B	879.93M	833.57M	966.44M	1.03B	982.05M	883.49M
Research & Development	787.6M	592.01M	751.3M	457.27M	790.83M	911.41M	1.21B	1.24B	899.8M	899.34M	713.97M	692.35M	483.86M	428.5M	261.27M	205.55M	188.68M
Other Expenses	-402.14M	-252.16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.76B	1.26B	1.65B	922.39M	1.62B	1.43B	1.98B	2.97B	5.43B	5.23B	3.71B	814.92M	529.7M	422.84M	213.4M	319.82M	583.99M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	655.72M	442.26M	442.13M	229.64M	490.56M	493.2M	629.72M	496.24M	381.9M	415.53M	389.05M	427.73M	328.6M	317.54M	216.79M	238.95M	210.97M
Cost & Expenses	2.66B	1.82B	2.42B	1.38B	2.52B	2.15B	2.97B	3.82B	6.28B	6.1B	4.54B	1.69B	1.54B	1.72B	1.63B	1.76B	1.98B
Income Tax Expense	145.17M	96.43M	237.83M	151.94M	377.21M	310.88M	444.3M	272.21M	423.81M	488.38M	570.02M	426.25M	384.98M	550.38M	629.45M	1.03B	969.47M
Shares Outstanding (Basic)	9.28B	8.91B	9.31B	9.39B	9.39B	9.52B	9.52B	9.47B	9.49B	9.47B	9.47B	9.47B	9.47B	9.47B	9.49B	9.92B	10.36B
Shares Outstanding (Diluted)	9.28B	9.28B	9.31B	9.33B	9.33B	9.52B	9.52B	9.47B	9.47B	9.47B	9.47B	9.47B	9.47B	9.47B	9.49B	9.92B	10.36B
EPS (Basic)	-0.01	-0.01	-0.00	0.00	0.07	0.10	0.12	-0.02	-0.27	-0.19	-0.04	0.24	0.23	0.25	0.26	0.23	0.27
EPS (Diluted)	-0.01	-0.01	-0.00	0.00	0.07	0.10	0.12	-0.02	-0.27	-0.19	-0.04	0.24	0.23	0.25	0.26	0.23	0.27
EBITDA	154.04M	40.21M	406.87M	237.95M	1.13B	1.23B	1.61B	1.14B	2.01B	2.54B	3.12B	2.65B	2.68B	2.9B	3.13B	3.31B	3.26B
EBIT	-135.89M	-140.54M	135.16M	74.66M	825.84M	989.08M	1.24B	843.72M	1.64B	2.26B	2.76B	2.39B	2.33B	2.57B	2.73B	2.96B	2.9B
Depreciation & Amortization	289.93M	180.75M	271.71M	163.29M	306.01M	241.89M	370.96M	300.49M	363.56M	287.02M	355.86M	261.05M	355.52M	324.37M	392.92M	349.11M	355.15M